LL
Schedule 13G filing
LYTTON LAURENCE W disclosed a 7.4% stake in Retension Pharmaceuticals, Inc. (RTSN)
LYTTON LAURENCE W reported owning 7.4% of Retension Pharmaceuticals, Inc. (RTSN) (617,207 shares) in a Schedule 13G filed Oct 15, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 15, 2026
- Source
- Schedule 13G
More RTSN insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.